Does METHYLPREDNISOLONE Cause Bladder cancer recurrent? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Bladder cancer recurrent have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.0% of all adverse event reports for METHYLPREDNISOLONE.
8
Reports of Bladder cancer recurrent with METHYLPREDNISOLONE
0.0%
of all METHYLPREDNISOLONE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Bladder cancer recurrent From METHYLPREDNISOLONE?
Of the 8 reports, 1 (12.5%) resulted in death.
Is Bladder cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Bladder cancer recurrent?
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (231)
PIOGLITAZONE (130)
RANITIDINE (66)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (28)
MITOMYCIN (20)
PEMBROLIZUMAB (20)
ADALIMUMAB (19)
GEMCITABINE\GEMCITABINE (19)
METHOTREXATE (16)
GEMCITABINE (15)
Which METHYLPREDNISOLONE Alternatives Have Lower Bladder cancer recurrent Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE